Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting

被引:28
作者
Rodier, Simon Gabriel [1 ]
Bukur, Marko [1 ]
Moore, Samantha [1 ,2 ]
Frangos, Spiros George [1 ]
Tandon, Manish [1 ]
DiMaggio, Charles Joseph [1 ]
Ayoung-Chee, Patricia [1 ]
Marshall, Gary Thomas [1 ,3 ]
机构
[1] NYU, Bellevue Hosp Ctr, Dept Surg, Sch Med, 462 First Ave, New York, NY 10016 USA
[2] St Johns Univ, Coll Pharm & Hlth Sci, 8000 Utopia Pkwy, Queens, NY 11439 USA
[3] Med City Plano, 4001 W 15th St,Suite 200, Plano, TX 75093 USA
关键词
Trauma; Prophylactic anticoagulation; Weight-based anticoagulation; Anti-factor Xa assay;
D O I
10.1007/s00068-019-01215-0
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background Venous thromboembolism (VTE) is a common morbidity in trauma patients. Standard VTE chemoprophylaxis is often inadequate. We hypothesized that weight-based dosing would result in appropriate prophylaxis more reliably than fixed dosing. Methods All patients admitted to a Level 1 trauma center over a 6-month period were included unless contra-indications for VTE prophylaxis existed. A prospective adjusted-dosing group was compared to a retrospective uniform-dosing group. The adjusted-dosing approach consisted of initial weight-based dosing of 0.5 mg/kg subcutaneously (subQ) every 12 h (q12h). Peak anti-factor Xa was measured. Patients outside of the prophylactic range had their dose adjusted by +/- 10 mg. The uniform-dosing group received 30 mg subQ q12h, without adjustments. Results Eighty-four patients were included: 44 in the retrospective control cohort and 40 in the prospective experimental cohort. More patients were sub-prophylactically dosed in the uniform-dosing group relative to the adjusted-dosing group (25% vs 5%, p = 0.03). There was no difference in overall prophylactic range targeting, because the supra-prophylactically dosed patients in the adjusted-dosing group eliminated the effect (p = 0.173). However, after a single dose adjustment, zero patients were outside of prophylactic range (25% versus 0%, RR = infinite, p = 0.003). In the uniform-dosing group, anti-Xa level correlated with body surface area (BSA; R-2 = 0.33, p < 0.0001) and weight (R-2 = 0.26, p = 0.0005). Weight-based dosing both pre- and post-readjustment normalized the correlation of anti-Xa with BSA (R-2 = 0.07, p = 0.1) and weight (R-2 = 0.07, p = 0.1). Conclusions Weight-based VTE prophylaxis with anti-Xa-based dose adjustment improves prophylactic range targeting relative to uniform dosing and eliminates variances secondary to BSA and weight in trauma patients.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 15 条
[1]  
[Anonymous], 2013, J BLOOD DISORD TRANS, DOI DOI 10.4172/2155-9864.1000151
[2]   If some is good, more is better: An enoxaparin dosing strategy to improve pharmacologic venous thromboembolism prophylaxis [J].
Berndtson, Allison E. ;
Costantini, Todd W. ;
Lane, James ;
Box, Kevin ;
Coimbra, Raul .
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2016, 81 (06) :1095-1100
[3]   Weight-based enoxaparin dosing for venous thromboembolism prophylaxis in the obese trauma patient Discussion [J].
Margulies, Daniel ;
Bickford, Annika ;
Biffl, Walter .
AMERICAN JOURNAL OF SURGERY, 2013, 206 (06) :851-852
[4]   Dose adjusting enoxaparin is necessary to achieve adequate venous thromboembolism prophylaxis in trauma patients [J].
Costantini, Todd W. ;
Min, Emily ;
Box, Kevin ;
Vy Tran ;
Winfield, Robert D. ;
Fortlage, Dale ;
Doucet, Jay ;
Bansal, Vishal ;
Coimbra, Raul .
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2013, 74 (01) :128-133
[5]   A PROSPECTIVE-STUDY OF VENOUS THROMBOEMBOLISM AFTER MAJOR TRAUMA [J].
GEERTS, WH ;
CODE, KI ;
JAY, RM ;
CHEN, EL ;
SZALAI, JP .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (24) :1601-1606
[6]   Prevention of venous thromboembolism [J].
Geerts, William H. ;
Bergqvist, David ;
Pineo, Graham F. ;
Heit, John A. ;
Samama, Charles M. ;
Lassen, Michael R. ;
Colwell, Clifford W. .
CHEST, 2008, 133 (06) :381S-453S
[7]   Posttrauma thromboembolism prophylaxis [J].
Greenfield, LJ ;
Proctor, MC ;
Rodriguez, JL ;
Luchette, FA ;
Cipolle, MD ;
Cho, J .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1997, 42 (01) :100-103
[8]  
Heit JA, 2005, BLOOD, V106, p267A
[9]   Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma [J].
Ko, Ara ;
Harada, Megan Y. ;
Barmparas, Galinos ;
Chung, Kevin ;
Mason, Russell ;
Yim, Dorothy A. ;
Dhillon, Navpreet ;
Margulies, Daniel R. ;
Gewertz, Bruce L. ;
Ley, Eric J. .
JAMA SURGERY, 2016, 151 (11) :1006-1013
[10]  
Ludwig KP, 2011, ANN PHARMACOTHER, V45, P1356, DOI [10.1345/aph.1Q313, 10.1345/aph.1P371]